Drug Trial Radar · NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
6,000
Planned (sponsor's estimate)
Start
Sep 26, 2022
Primary completion
Mar 1, 2029
Study completion Mar 1, 2029
Sponsor
- Lead sponsor
- Brigham and Women's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Patient-Centered Outcomes Research Institute
- First posted
- May 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.
Conditions
- Type2Diabetes
- ASCVD
Interventions
SGLT2 inhibitorDrug
Empagliflozin, dapagliflozin, or canagliflozin
GLP-1 receptor agonistDrug
Dulaglutide, liraglutide, semaglutide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total (first and recurrent) cardiovascular, kidney, and death eventsTime frame: Through study completion, with an average follow up of approximately 3 years
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Longwood Research LLC
Huntsville, Alabama · Recruiting
HonorHealth Research & Innovation Institute
Scottsdale, Arizona · Recruiting
Eastside Clinical Research Associates
Los Angeles, California · Recruiting
Kendall South Medical Center, Inc
Miami, Florida · Recruiting
South Florida Research Solutions, LLC
Pembroke Pines, Florida · Recruiting
NSC Research, Inc.
Johns Creek, Georgia · Recruiting
Herman Clinical Research
Suwanee, Georgia · Recruiting
University of Illinois Chicago
Chicago, Illinois · Recruiting
Rush University Medical Center
Hinsdale, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
University of Kansas Medical Center
Fairway, Kansas · Recruiting
Johns Hopkins School of Medicine
Baltimore, Maryland · Recruiting
MedStar Union Memorial Hospital
Baltimore, Maryland · Recruiting
MedStar Health Research Institute - Good Samaritan Hospital
Baltimore, Maryland · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
UMass Chan Medical School
Worcester, Massachusetts · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Essentia Health
Duluth, Minnesota · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
University of Missouri-Columbia
Columbia, Missouri · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Naomi Berrie Diabetes Center at New York Presbyterian-Columbia University
New York, New York · Recruiting
Atrium Health Family Medicine Research Department
Charlotte, North Carolina · Recruiting
Duke University Hospital
Durham, North Carolina · Recruiting
Wooster Heart Group
Wooster, Ohio · Recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
Geisinger Medical Center
Danville, Pennsylvania · Recruiting
Temple University Lewis Katz School of Medicine
Philadelphia, Pennsylvania · Recruiting
Family Care Center at Kent Hospital
Pawtucket, Rhode Island · Recruiting
Medical University of South Carolina
Charleston, South Carolina · Recruiting
South Carolina Clinical Research, LLC
Orangeburg, South Carolina · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
Premier Internal Medicine Associates of Houston
Katy, Texas · Recruiting
North Dallas Research Associates
McKinney, Texas · Recruiting
Kidney and Hypertension Specialists, PLLC
Manassas, Virginia · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.